Bio-Rad Labs Inc. A buy Royal Bank of Canada
Start price
02.08.24
/
50%
€307.80
Target price
02.08.25
€367.36
Performance (%)
0.00%
Price
02.08.24
€307.80
Summary
This prediction is currently active. Royal_Bank_of_Canada's BUY prediction for Bio-Rad Labs Inc. A is currently unchanged. This prediction currently runs until 02.08.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Bio-Rad Labs Inc. A | 0.00% |
iShares Core DAX® | -1.377% |
iShares Nasdaq 100 | 0.827% |
iShares Nikkei 225® | 0.198% |
iShares S&P 500 | 1.364% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at Royal Bank of Canada from $402.00 to $401.00. They now have an "outperform" rating on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€445.58
16.02.25
16.02.25
-2.66%
02.08.24
02.08.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€363.40
04.08.23
04.08.23
€474.64
04.08.24
04.08.24
-15.30%
02.08.24
02.08.24